GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: The American Journal of Cardiology, Elsevier BV, Vol. 204 ( 2023-10), p. 325-332
    Type of Medium: Online Resource
    ISSN: 0002-9149
    RVK:
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2023
    detail.hit.zdb_id: 2019595-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Circulation, Ovid Technologies (Wolters Kluwer Health), Vol. 146, No. Suppl_1 ( 2022-11-08)
    Abstract: Introduction: Coronary artery ectasia is associated with an increased risk of acute myocardial infarction. Hypothesis: This meta-analysis evaluates outcomes following acute myocardial infarction in patients with preexisting coronary artery ectasia. Methods: This meta-analysis was conducted according to PRISMA guidelines. A search strategy was designed to utilize PubMed/Medline, EMBASE, and Google scholar for studies showing the outcomes of acute myocardial infarction in patients with coronary artery ectasia from inception to February 10, 2022. We reported effect sizes as odds ratio (OR) with a 95% confidence interval (CI). We used I 2 statistics to estimate the extent of unexplained statistical heterogeneity: I 2 greater than 50% was considered a high degree of between-study statistical heterogeneity. Results: Of 217 studies initially identified, 7 studies comprising 13499 patients were included in the final analysis. There was no significant difference between patients with coronary ectasia and patients without coronary ectasia in terms of all-cause mortality (OR 0.95; 95% CI 0.58 to 1.56; p = 0.79; I 2 =0%) , MACE (OR 4.04; 95% CI 0.34 to 47.57; p = 0.17; I 2 =95%), myocardial reinfarction (OR 2.13; 95% CI 0.83 to 5.47; p = 0.08; I 2 =59%), target vessel revascularization (OR 1.31; 95% CI 0.69 to 2.48; p = 0.21; I 2 =0%), or requiring mechanical supportive devices (OR 1.32; 95% CI 0.22 to 7.83; p = 0.57; I 2 =56%). (Figures 2-A, B, C, D) Conclusions: Acute myocardial infarction in the presence of coronary artery ectasia is not linked to an increased risk of death, major cardiovascular events, myocardial infarction, or the need for mechanical circulatory support.
    Type of Medium: Online Resource
    ISSN: 0009-7322 , 1524-4539
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2022
    detail.hit.zdb_id: 1466401-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Circulation, Ovid Technologies (Wolters Kluwer Health), Vol. 146, No. Suppl_1 ( 2022-11-08)
    Abstract: Introduction: Acetaminophen-induced hypotension has been reported previously. It is uncertain whether acetaminophen directly impacts blood pressure and heart rate. Hypothesis: The meta-analysis investigates the effects of acetaminophen on the blood pressure and heart rate, and whether there is a dose-response relationship. Methods: This meta-analysis was conducted according to PRISMA guidelines. A search strategy was designed to utilize PubMed/Medline, EMBASE, and Google scholar for studies showing the effects of acetaminophen on blood pressure and heart rate from inception to February 20, 2022. After screening, 14 clinical trials were included in the analysis. Dichotomous data were pooled as relative risk (RR) and continuous data as mean difference (MD) or standardized mean difference (SMD) using the inverse-variance method. Heterogeneity was assessed using the Cochrane Q test, and its extent was determined by I-square (A value of more than 50% was considered a significant heterogeneity). Results: No statistically significant difference between acetaminophen and control for the overall effect on SBP (MD= -1.52, 95% CI = -4.66 to 1.61, p-value = 0.34) was observed. The findings remained consistent in subgroup analysis by dose, across one gram or less (p-value = 0.54), and more than one gram (p-value = 0.43). Similarly, no statistically significant difference was found for the overall effect on DBP (p-value = 0.61) although we found a statistically significant difference in DBP in the one gram or less subgroup (p-value = 0.02). Finally, we report no statistically significant difference between acetaminophen and control on the MAP (p-value = 0.32) and HR (p-value = 0.18). Conclusions: Acetaminophen has no significant effect on SBP, DBP, MAP, and HR. This effect is consistent with different doses except for a possible increase in DBP after using one gram or less. Further studies are needed to investigate the relevance of this effect.
    Type of Medium: Online Resource
    ISSN: 0009-7322 , 1524-4539
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2022
    detail.hit.zdb_id: 1466401-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Circulation, Ovid Technologies (Wolters Kluwer Health), Vol. 146, No. Suppl_1 ( 2022-11-08)
    Abstract: Introduction: The first-generation Watchman 2.5 (W2.5) is associated with several limitations, including the difficulty of implantation in complex LAA anatomies, peri device leak, device recapture and device-related thrombosis. The second-generation Watchman FLX (W-FLX) addressed those limitations with proven safety and efficacy of the device. Hypothesis: This meta-analysis compares the safety and efficacy of the Watchman FLX and 2.5 devices. Methods: The meta-analysis was conducted according to PRISMA guidelines. Studies were located through a search strategy utilizing PubMed, Google scholar and MEDLINE from inception to March 20, 2022, with a primary objective to compare the safety and efficacy of the W-FLX and W2.5. After setting inclusion and exclusion criteria, we identified three recently published observational studies. Results: Our analysis included 3 studies comprising 401 patients. New generation W- FLX is associated with less incidence of major-leak compared to the first-generation W 2.5, OR: 0.08 CI (0.06-0.12) P 〈 0.01 (Figure 1). There was no difference in mortality OR: 1.38 CI (0.00-152360) P .78, procedure success OR: 16.07 CI (0.06-4676.83) P 0.1 or post-procedural complications (Bleeding OR: 0.63 CI (0.03-13.07) P 0.31, device embolization OR: 0.12 CI (0.00-3.79) P 0.08, pericardial effusion OR: 0.14 CI (0.00-12.23) P 0.11 or stroke OR: 0.7 CI (0.00-9170) P 0.71) across the two devices. Conclusions: The new generation Watchman FLX has a superior sealing capacity than the Watchman 2.5 with a similar safety profile.
    Type of Medium: Online Resource
    ISSN: 0009-7322 , 1524-4539
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2022
    detail.hit.zdb_id: 1466401-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...